does noom use glp 1 Why We Launched GLP-1RX Noom Launches Microdose GLP-1 Program,
Description
JAMA 2023;330:163140.ArticlePubMedPMC 37

Non-injectable treatment formats are becoming a strategic entry point for wider patient adoption, particularly for patients who are hesitant to start injectable GLP-1 therapies or may struggle with long-term injection adherence, storage requirements, and administration fatigue
Small, frequent meals with protein, complex carbs, and hydration can help keep blood sugar and energy levels stable

K., Sommer, C

Enhanced GLP-1 secretion has been suggested to be a major mechanism underlying enhanced insulin secretion after bariatric surgery because blockade of GLP-1 action by treatment with the pharmacological antagonist exendin-9 decreased insulin secretion and ameliorated post-surgical glucose handling in both mice and humans [144]
Following the expiry of semaglutides patent in India (March 2021, 2026), the market changed dramatically.[13][14] 40+ Indian pharma companies launched generic GLP-1 medications[12] Prices dropped by ~80% Key players include: Sun Pharma Dr